Supportive Treatment of Severe Heart Failure by Renal Denervation
- Conditions
- Heart Failure
- Interventions
- Procedure: Renal nervous denervation
- Registration Number
- NCT02638324
- Lead Sponsor
- Turku University Hospital
- Brief Summary
The overactivity of sympathetic nervous system is worsening the hemodynamic state of heart failure patients. The present study is planned to reduce the sympathetic tone in patients with severe heart failure by renal nervous denervation.
- Detailed Description
The patient population consists of heart failure patients who are not responding properly to medication and biventricular pacing therapy. The inappropriate response to these therapies is evaluated by patient history (NYHA III-IV), echocardiography (EF \< 45%), 6-minute walking test (\<440m) and measurements of P-ProBNP. The patients who fulfill the inclusion criteria will undergo renal nervous denervation. The patients will be followed up with the same methods as they were recruited to the study (by patient history (NYHA III-IV), echocardiography (EF \< 45%), 6-minute walking test (\<440m) and measurements of P-ProBNP). The overall time of follow-up will be 24 months. The patients are randomised according to the waiting list principle in a manner to 1:1. The waiting time will be 6 months.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 40
- NYHA III-IV
- ejection fraction <45 %
- 6-minute walking test under 440m
- Unstable hemodynamic state
- uncooperation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Renal nervous denervation. Renal nervous denervation Renal nervous denervation is performed to the patients who do not response properly to conventional therapy. The patients are randomised according to the waiting list principle. Renal nervous denervation (delayed) Renal nervous denervation Renal nervous denervation is performed after six months on the waiting list
- Primary Outcome Measures
Name Time Method 6-minute walking test 24 months Composite outcome measure
- Secondary Outcome Measures
Name Time Method Cardiac echocardiography 24 months Composite outcome measure
Patient history 24 months Composite outcome measure
P-proBNP 24 months Composite outcome measure
Trial Locations
- Locations (1)
Vaasa Central Hospital
🇫🇮Vaasa, Finland